In pancreatic cancer, increased transcription leads to overexpression of c-MET, which is one of the most common causes of constitutive c-MET activation, and this increased c-MET promotes tumour occurrence and development through multiple mechanisms (7). Here, MET is linked to familial pancreatic carcinoma.